AMSTERDAM · EST. 2026
Onpeps
PEPTIDE DECISION INTELLIGENCE
Subscribe
← PEPTIDE LIBRARY
RECOVERYGRADE DSPECULATIVE / THIN

BPC-157

Cytoprotective peptide; angiogenesis and growth-factor signalling

A synthetic pentadecapeptide derived from a sequence found in gastric juice. The preclinical record for tendon, ligament and gut-lining repair is substantial, but human data remain very limited.

ALSO KNOWN AS Body Protection Compound-157 · PL 14736 · Pentadecapeptide BPC 157
REGULATORY STATUS · RESEARCH COMPOUND

Research compound — not approved for human use. Compounds in this category have not been approved for human use; availability is typically restricted to laboratory research.

§ EVIDENCE BASE
214
PUBLICATIONS
indexed in PubMed
2
REGISTERED TRIALS
listing it as an intervention
1
PHASE 2–4 TRIALS
reached later-stage testing
MECHANISMCytoprotective peptide; angiogenesis and growth-factor signalling
CATEGORYRecovery
EVIDENCE GRADED — Speculative / thin
STATUSResearch compound — not approved for human use
TYPICAL RECONSTITUTION5 mg vial + 2 mL BAC water (2,500 mcg/mL)
ROUTESubcutaneous, or oral in the arginate form
COUNTS RETRIEVED2026-07-23 · re-run the PubMed query
§ DOCUMENTED DOSING
Standard250–500 mcg once or twice daily
Injury sitedose near the affected area where practical
Cycle4–8 weeks, then reassess

Ranges compiled from published protocols, not a clinical guideline. Convert a dose into syringe units with the dosage calculator.

FURTHER READING
The Complete BPC-157 Dosage Guide
§ RELATED COMPOUNDS
RECOVERYB
Thymosin Beta-4
Actin-sequestering protein; cell migration and angiogenesis
RECOVERYD
KPV
α-MSH C-terminal tripeptide; anti-inflammatory
RECOVERYD
TB-500
Actin-sequestering peptide (Thymosin β4 fragment)
NOT MEDICAL ADVICE

This page summarises how much a compound has been studied. A high publication count is not evidence that something works, is safe, or is legal to obtain where you live. Consult a qualified healthcare provider before acting on anything here.

THE WEEKLY BRIEF

Peptide intelligence, every Monday.

One concise email: the newest research, evidence updates, and quality signals — no hype, no spam.

Onpeps

Our mission is to make peptide research clear, credible, and usable for people who refuse to rely on hype.

EXPLORE
FOLLOW
PEPTIDE INFORMATION YOU CAN VERIFY© 2026 ONPEPS · AMSTERDAM, NETHERLANDS · NOT MEDICAL ADVICE